Keyphrases
Inhibitor Resistant
100%
MiR-524-5p
100%
Melanoma
100%
BRAF Inhibitor (BRAFi)
100%
Partial Response
18%
Overexpression
9%
Biological Function
9%
Genome Sequence Analysis
9%
Receptor Activation
9%
Prognostic Marker
9%
Tumor Suppressor
9%
Anchorage-independent Growth
9%
Resistant Cells
9%
Invasive Ability
9%
Complete Response
9%
ERK MAPK
9%
BRAF-mutant Melanoma
9%
Retinoid X Receptor
9%
Migratory Ability
9%
Nevus
9%
Melanoma Cells
9%
Acquired Resistance
9%
Complement System
9%
Liver X Receptor
9%
Growth Ability
9%
Leukocyte Extravasation
9%
Progressive Disease
9%
Immunology and Microbiology
Biological Functions
100%
Next Generation Sequencing
100%
Melanoma Cell
100%
Leukocyte Extravasation
100%
Complement System
100%
Anchorage Independent Growth
100%
Medicine and Dentistry
Melanoma
100%
Biological Functions
11%
Cancer
11%
Mitogen-Activated Protein Kinase
11%
Biological Marker
11%
Next Generation Sequencing
11%
Cell Signaling Pathway
11%
Retinoid X Receptor
11%
Melanoma Cell
11%
Leukocyte Extravasation
11%
Progressive Disease
11%
Liver X Receptor
11%
Complement System
11%
Anchorage Independent Growth
11%
Tumor Suppressor Protein
11%
Nevus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Biological Marker
10%
Retinoid X Receptor
10%
Liver X Receptor
10%
Nevus
10%
Extravasation
10%
Tumor Suppressor Protein
10%
Diseases
10%